IP Verse

Ascendis Pharma Growth Disorders competitive analysis

Loading summary...

Latest oppositions filed by Ascendis Pharma Growth Disorders

Explore patent oppositions filed by Ascendis Pharma Growth Disorders against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3175863
Variants Of C-Type Natriuretic PeptideBIOMARIN PHARMACEUTICALSep 1, 2022

Latest publications and patents of Ascendis Pharma Growth Disorders New

Explore the latest publications and patents granted to Ascendis Pharma Growth Disorders, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Ascendis Pharma Growth Disorders

EP2512450
Feb 7, 2018Dry Growth Hormone Composition Transiently Linked To A Polymer CarrierNo Opposition Filed Within Time Limit

Latest PTAB cases involving Ascendis Pharma Growth Disorders

Discover the latest PTAB cases involving Ascendis Pharma Growth Disorders, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ascendis Pharma Growth Disorders with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ASCENDIS PHARMA GROWTH DISORDERS1 - - -
BIOMARIN PHARMACEUTICAL - 183 -